People

Luc Dochez

droiaventures.com

Luc Dochez is a QurAlis director and biotechnology investor associated with Droia. His published biography describes leadership at Tusk Therapeutics and Prosensa, earlier roles at TiGenix and Arthur D. Little, and pharmacy, economics and MBA training in Belgium. Luc Dochez is named Managing Partner Genetic Disease in Droia’s current public directory. The published professional background includes Pharm.D., University of Leuven; MBA, Vlerick Management School; Arthur D. Little; TiGenix; Prosensa; Tusk Therapeutics; Independent board member Erytech, Pharvaris. This is a manager-published affiliation; advisory-board membership and Droia Labs scientific roles are qualified separately from the investment team. Exact appointment dates and personal cash participation are not inferred.